1.Computed Tomography-Derived Myosteatosis and Metabolic Disorders
Iva MILJKOVIC ; Chantal A. VELLA ; Matthew ALLISON
Diabetes & Metabolism Journal 2021;45(4):482-491
The role of ectopic adipose tissue infiltration into skeletal muscle (i.e., myosteatosis) for metabolic disorders has received considerable and increasing attention in the last 10 years. The purpose of this review was to evaluate and summarize existing studies focusing on computed tomography (CT)-derived measures of myosteatosis and metabolic disorders. There is consistent evidence that CT-derived myosteatosis contributes to dysglycemia, insulin resistance, type 2 diabetes mellitus, and inflammation, and, to some extent, dyslipidemia, independent of general obesity, visceral fat, and other relevant risk factors, suggesting that it may serve as a tool for metabolic risk prediction. Identification of which muscles should be examined, and the standardized CT protocols to be employed, are necessary to enhance the applicability of findings from epidemiologic studies of myosteatosis. Additional and longer longitudinal studies are necessary to confirm a role of myosteatosis in the development of type 2 diabetes mellitus, and examine these associations in a variety of muscles across multiple race/ethnic populations. Given the emerging role of myosteatosis in metabolic health, well-designed intervention studies are needed to investigate relevant lifestyle and pharmaceutical approaches.
2.Computed Tomography-Derived Myosteatosis and Metabolic Disorders
Iva MILJKOVIC ; Chantal A. VELLA ; Matthew ALLISON
Diabetes & Metabolism Journal 2021;45(4):482-491
The role of ectopic adipose tissue infiltration into skeletal muscle (i.e., myosteatosis) for metabolic disorders has received considerable and increasing attention in the last 10 years. The purpose of this review was to evaluate and summarize existing studies focusing on computed tomography (CT)-derived measures of myosteatosis and metabolic disorders. There is consistent evidence that CT-derived myosteatosis contributes to dysglycemia, insulin resistance, type 2 diabetes mellitus, and inflammation, and, to some extent, dyslipidemia, independent of general obesity, visceral fat, and other relevant risk factors, suggesting that it may serve as a tool for metabolic risk prediction. Identification of which muscles should be examined, and the standardized CT protocols to be employed, are necessary to enhance the applicability of findings from epidemiologic studies of myosteatosis. Additional and longer longitudinal studies are necessary to confirm a role of myosteatosis in the development of type 2 diabetes mellitus, and examine these associations in a variety of muscles across multiple race/ethnic populations. Given the emerging role of myosteatosis in metabolic health, well-designed intervention studies are needed to investigate relevant lifestyle and pharmaceutical approaches.
3.Divorcing Diagnosis From Treatment: Contemporary Management of Low-Risk Prostate Cancer.
Allison S GLASS ; Sanoj PUNNEN ; Matthew R COOPERBERG
Korean Journal of Urology 2013;54(7):417-425
Today, the majority of men with newly diagnosed prostate cancer will present with low-risk features of the disease. Because prostate cancer often takes an insidious course, it is debated whether the majority of these men require radical treatment and the accompanying derangement of quality of life domains imposed by surgery, radiation, and hormonal therapy. Investigators have identified various selection criteria for "insignificant disease," or that which can be monitored for disease progression while safely delaying radical treatment. In addition to the ideal definition of low risk, a lack of randomized trials comparing the various options for treatment in this group of men poses a great challenge for urologists. Early outcomes from active surveillance cohorts support its use in carefully selected men with low-risk disease features, but frequent monitoring is required. Patient selection and disease monitoring methods will require refinement that will likely be accomplished through the increased use of biomarkers and specialized imaging techniques.
Biomarkers
;
Cohort Studies
;
Disease Management
;
Disease Progression
;
Humans
;
Male
;
Patient Selection
;
Prostate
;
Prostatic Neoplasms
;
Quality of Life
;
Research Personnel
4.Associations between Weight-Adjusted Waist Index and Abdominal Fat and Muscle Mass: Multi-Ethnic Study of Atherosclerosis
Ji Yoon KIM ; Jimi CHOI ; Chantal A. VELLA ; Michael H. CRIQUI ; Matthew A. ALLISON ; Nam Hoon KIM
Diabetes & Metabolism Journal 2022;46(5):747-755
Background:
The weight-adjusted waist index (WWI) reflected body compositional changes with aging. This study was to investigate the association of WWI with abdominal fat and muscle mass in a diverse race/ethnic population.
Methods:
Computed tomography (CT) data from 1,946 participants for abdominal fat and muscle areas from the Multi-Ethnic Study of Atherosclerosis (785 Whites, 252 Asians, 406 African American, and 503 Hispanics) were used. Among them, 595 participants underwent repeated CT. The WWI was calculated as waist circumference (cm) divided by the square root of body weight (kg). The associations of WWI with abdominal fat and muscle measures were examined, and longitudinal changes in abdominal composition measures were compared.
Results:
In all race/ethnic groups, WWI was positively correlated with total abdominal fat area (TFA), subcutaneous fat area, and visceral fat area, but negatively correlated with total abdominal muscle area (TMA) and abdominal muscle radiodensity (P<0.001 for all). WWI showed a linear increase with aging regardless of race and there were no significant differences in the WWI distribution between Whites, Asians, and African Americans. In longitudinal analyses, over 38.6 months of follow-up, all abdominal fat measures increased but muscle measures decreased, along with increase in WWI. The more the WWI increased, the more the TFA increased and the more the TMA decreased.
Conclusion
WWI showed positive associations with abdominal fat mass and negative associations with abdominal muscle mass, which likely reflects the abdominal compositional changes with aging in a multi-ethnic population.
5.Associations of Perirenal Fat Thickness with Renal and Systemic Calcified Atherosclerosis
Bo Kyung KOO ; Julie O DENENBERG ; C Michael WRIGHT ; Michael H CRIQUI ; Matthew A ALLISON
Endocrinology and Metabolism 2020;35(1):122-131
BACKGROUND:
We investigated associations between perirenal fat thickness and atherosclerotic calcification in six different vascular beds.
METHODS:
Using a community-based cohort (n=3,919), perirenal fat thickness was estimated from computed tomography scans. It was classified as Q1 (the lowest quartile) to Q4 (the highest quartile) in each sex. Calcification in the carotid arteries, coronary arteries, thoracic aorta, abdominal aorta, iliac arteries, and renal arteries was evaluated.
RESULTS:
Perirenal fat thickness was associated with older age (P<0.01) and a higher prevalence of obesity, hypertension, and dyslipidemia (P<0.01 for all). Perirenal fat thickness was independently associated with renal arterial calcification even after adjustment for age, sex, body mass index, hypertension, dyslipidemia, smoking history, and family history of heart diseases in first-degree relatives (odds ratio [OR] per quartile of perirenal fat thickness, 1.25; 95% confidence interval [CI], 1.09 to 1.44). Compared to Q1, the odds of renal arterial calcification in Q4 was about two times higher (OR, 2.05; 95% CI, 1.29 to 3.25). After adjustment for renal arterial calcification and atherosclerotic risk factors, the only other vascular bed where perirenal fat thickness showed a significant association with calcification was the abdominal aorta (OR, 1.11; 95% CI, 1.00 to 1.23; P=0.045).
CONCLUSION
Perirenal fat thickness was independently associated with vascular calcification in the renal artery and abdominal aorta.
6.Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.
Mark D GONZALEZ ; Allison R MCMULLEN ; Meghan A WALLACE ; Matthew P CROTTY ; David J RITCHIE ; Carey Ann D BURNHAM
Annals of Laboratory Medicine 2017;37(2):174-176
No abstract available.
Anti-Bacterial Agents/*pharmacology
;
Azabicyclo Compounds/*pharmacology
;
Bacterial Proteins/genetics
;
Ceftazidime/*pharmacology
;
Cephalosporins/*pharmacology
;
DNA, Bacterial/genetics/metabolism
;
Drug Resistance, Bacterial/*drug effects
;
Gram-Negative Bacteria/drug effects/*isolation & purification
;
Humans
;
Microbial Sensitivity Tests
;
Penicillanic Acid/*analogs & derivatives/pharmacology
;
Pseudomonas aeruginosa/drug effects/isolation & purification
;
Real-Time Polymerase Chain Reaction
7.Ultrasound-guided percutaneous intercostal nerve cryoneurolysis for analgesia following traumatic rib fracture -a case series-
John J. FINNERAN IV ; Rodney A. GABRIEL ; Matthew W. SWISHER ; Allison E. BERNDTSON ; Laura N. GODAT ; Todd W. COSTANTINI ; Brian M. ILFELD
Korean Journal of Anesthesiology 2020;73(5):455-459
Background:
Rib fractures are a common injury in trauma patients and account for significant morbidity and mortality within this population. Local anesthetic-based nerve blocks have been demonstrated to provide significant pain relief and reduce complications. However, the analgesia provided by these blocks is limited to hours for single injection blocks or days for continuous infusions, while the duration of this pain often lasts weeks. Case: This case series describes five patients with rib fractures whose pain was successfully treated with cryoneurolysis.
Conclusions
Ultrasound-guided percutaneous cryoneurolysis is a modality that has the potential to provide analgesia matching the duration of pain following rib fractures.
8.Systematic sequencing of imported cases leads to detection of SARS-CoV-2 B.1.1.529 (Omicron) variant in central Viet Nam
Do Thai Hung ; Nguyen Bao Trieu ; Do Thi Thu Thuy ; Allison Olmsted ; Trinh Hoang Long ; Nguyen Duc Duy ; Huynh Kim Mai ; Bui Thi Thu Hien ; Nguyen Van Van ; Tran Van Kiem ; Vo Thi Thuy Trang ; Nguyen Truong Duy ; Ton That Thanh ; Huynh Van Dong ; Philip L Gould ; Matthew R Moore
Western Pacific Surveillance and Response 2022;13(4):82-85
As authorities braced for the arrival of the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infrastructure investments and government directives prompted action in central Viet Nam to establish capacity for genomic surveillance sequencing. From 17 November 2021 to 7 January 2022, the Pasteur Institute in Nha Trang sequenced 162 specimens from 98 150 confirmed SARS-CoV-2 cases in the region collected from 8 November to 31 December 2021. Of these, all 127 domestic cases were identified as the B.1.617.2 (Delta) variant, whereas 92% (32/35) of imported cases were identified as the B.1.1.529 (Omicron) variant, all among international flight passengers. Patients were successfully isolated, enabling health-care workers to prepare for additional cases. Most (78%) of the 32 Omicron cases were fully vaccinated, suggesting continued importance of public health and social measures to control the spread of new variants.